Finance

Lists
VTGN:NASDAQ
Vistagen Therapeutics Inc
0,17 USD
-0,48%
(-0,00080) 1D
0,17 USD
+0,78% (+0,0013)
After hours
Closed: 2-ноя., 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VTGN...
Open
0,17 USD
High
0,17 USD
Low
0,17 USD
Mkt. cap
7,36 млн
Avg. vol.
21,28 млн
Volume
842,62 миң
52-wk high
5,14 USD
52-wk low
0,17 USD
EPS
-1,68 USD
Beta
0,34
Shares outstanding
44,38 млн
No. of employees
41
Open
0,17 USD
High
0,17 USD
Low
0,17 USD
Mkt. cap
7,36 млн
Avg. vol.
21,28 млн
Volume
842,62 миң
52-wk high
5,14 USD
52-wk low
0,17 USD
EPS
-1,68 USD
Beta
0,34
Shares outstanding
44,38 млн
No. of employees
41
News stories
From web sources and news partners
MarketWatch
MarketWatch
·
32 мүнөт мурун
Nasdaq-100 tumbles into its third correction this year as AI worries mount
GuruFocus
GuruFocus
·
14 мүнөт мурун
Lotus Technology (LOT) Receives Nasdaq Notice for Minimum Bid Pr
Quantisnow
Quantisnow
·
28 мүнөт мурун
XMAX
Bloomberg.com
Bloomberg.com
·
1 саат мурун
Nasdaq Slide Clouds Asian Open, Oil Holds Losses: Markets Wrap
About Vistagen Therapeutics Inc
CEO-
Employees41
Founded1998
HeadquartersЮг Сан Франциско, Калифорния, Америка Кошмо Штаттары
Sector-
Websitevistagen.com
Analyst ratings
Based on 1 analyst giving stock ratings to VTGN in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for VTGN in the last 3 months
Highest
Current 0,17 USD
(-100,00%)
Average
(-100,00%)
Lowest
(-100,00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Myles Minter
William Blair
Hold
Maintained
-
-
09/23/2026
Paul Matteis
Stifel Nicolaus
Hold
Maintained
1,00 USD
+497%
07/06/2026
Andrew Tsai
Jefferies
Hold
Downgraded
0,90 USD
+437,3%
12/17/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
258,00 миң
303,00 миң
465,00 миң
1,48 млн
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
15,92 млн
14,22 млн
13,06 млн
10,91 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,40 млн
5,63 млн
4,12 млн
3,92 млн
Operating expense
20,31 млн
19,85 млн
17,18 млн
14,82 млн
Total operating expenses
20,31 млн
19,85 млн
17,18 млн
14,82 млн
Operating income
-20,05 млн
-19,55 млн
-16,72 млн
-13,35 млн
Other non operating income
6,00 миң
-
-2,00 миң
-1,00 миң
EBT including unusual items
-19,42 млн
-18,90 млн
-16,27 млн
-13,03 млн
EBT excluding unusual items
-19,42 млн
-18,90 млн
-16,27 млн
-13,03 млн
Income tax expense
-
-
7,00 миң
-
Effective tax rate
-
-
-0,04%
-
Other operating expenses
-
-
-
-
Net income
-19,42 млн
-18,90 млн
-16,27 млн
-13,03 млн
Net profit margin
-7 525,97%
-6 237,29%
-3 499,78%
-882,79%
Earnings per share
-0,54
-0,45
-0,37
-0,30
Interest and investment income
630,00 миң
647,00 миң
452,00 миң
319,00 миң
Interest expense
-
-
-
-
Net interest expenses
630,00 миң
647,00 миң
452,00 миң
319,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-20,00 млн
-19,49 млн
-16,66 млн
-13,30 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору